1. Home
  2. GERN vs FSUN Comparison

GERN vs FSUN Comparison

Compare GERN & FSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • FSUN
  • Stock Information
  • Founded
  • GERN 1990
  • FSUN 1892
  • Country
  • GERN United States
  • FSUN United States
  • Employees
  • GERN N/A
  • FSUN N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • FSUN Major Banks
  • Sector
  • GERN Health Care
  • FSUN Finance
  • Exchange
  • GERN Nasdaq
  • FSUN Nasdaq
  • Market Cap
  • GERN 974.5M
  • FSUN 997.3M
  • IPO Year
  • GERN 1996
  • FSUN N/A
  • Fundamental
  • Price
  • GERN $1.32
  • FSUN $37.51
  • Analyst Decision
  • GERN Buy
  • FSUN Buy
  • Analyst Count
  • GERN 8
  • FSUN 4
  • Target Price
  • GERN $3.71
  • FSUN $47.33
  • AVG Volume (30 Days)
  • GERN 9.4M
  • FSUN 205.1K
  • Earning Date
  • GERN 08-07-2025
  • FSUN 08-27-2025
  • Dividend Yield
  • GERN N/A
  • FSUN N/A
  • EPS Growth
  • GERN N/A
  • FSUN N/A
  • EPS
  • GERN N/A
  • FSUN 3.07
  • Revenue
  • GERN $116,293,000.00
  • FSUN $374,445,000.00
  • Revenue This Year
  • GERN $160.12
  • FSUN $18.18
  • Revenue Next Year
  • GERN $55.01
  • FSUN $6.75
  • P/E Ratio
  • GERN N/A
  • FSUN $12.25
  • Revenue Growth
  • GERN 22264.04
  • FSUN 9.58
  • 52 Week Low
  • GERN $1.17
  • FSUN $31.70
  • 52 Week High
  • GERN $5.06
  • FSUN $45.32
  • Technical
  • Relative Strength Index (RSI)
  • GERN 40.66
  • FSUN 63.90
  • Support Level
  • GERN $1.36
  • FSUN $36.48
  • Resistance Level
  • GERN $1.48
  • FSUN $38.87
  • Average True Range (ATR)
  • GERN 0.09
  • FSUN 1.12
  • MACD
  • GERN -0.02
  • FSUN 0.36
  • Stochastic Oscillator
  • GERN 7.41
  • FSUN 78.60

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

Share on Social Networks: